Dr. Nierodzik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
NYU Langone Health
550 First Ave OBV C&D 556
New York, NY 10016Phone+1 212-263-3212Fax+1 212-263-3213- Is this information wrong?
Summary
- Dr. Mary Lynn Nierodzik is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including NYU Langone Hospitals and NYC Health + Hospitals / Bellevue. She received her medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 35 years. She specializes in hematologic oncology and is experienced in hematologic oncology and general / benign hematology.
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1986 - 1990
- SUNY Health Science Center at BrooklynResidency, Internal Medicine, 1982 - 1986
- State University of New York Downstate Medical Center College of MedicineClass of 1982
- Wagner CollegeB.S., Biology, 1978
- Bishop R.A. Kearney H.S.Certificate, 1974
Certifications & Licensure
- NY State Medical License 1985 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- NYU Teaching Attending of the Year in Oncology 2003
- NYU Teaching Attending of the Year in Hematology 2003
- Excellence Certificate in Graduate Medical Education NYU, Department of Medicine, 2001
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsTrisomy 8 in myeloid leukemia cutis confirmed by fluorescence in situ hybridization analysis.Marianna Shvartsbeyn, Shane Meehan, Ping Gu, Mary Lynn Nierodzik, Mary Ann Perle> ;Journal of Cutaneous Pathology. 2012 Aug 11
- 33 citationsPhase II study of darinaparsin in patients with advanced hepatocellular carcinomaJennifer Wu, Charles A. Henderson, Lynn G. Feun, Peter J. Van Veldhuizen, Philip J. Gold, Hui Zheng, Theresa Ryan, Lawrence S. Blaszkowsky, Haobin Chen, Max Costa, Bar...> ;Investigational New Drugs. 2010 Oct 1
- 373 citationsThrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotypeMary Lynn Nierodzik, Simon Karpatkin> ;Cancer Cell. 2006 Nov 1
- Join now to see all
Journal Articles
- Trisomy 8 in Myeloid Leukemia Cutis Confirmed by Fluorescence in Situ Hybridization AnalysisShvartsbeyn M, Meehan S, Gu P, Nierodzik ML, Perle MA, J Cutan Pathology, 1/1/2012
- Cancer Portal Project: A Multidisciplinary Approach to Cancer Care among Hispanic PatientsGany F, Ramirez J, Nierodzik ML, McNish T, Lobach I, Leng J, JOP, 1/1/2011
- Phase II Study of Darinisparin in Patients with Advanced Hepatocellular CarcinomaWu J, Nierodzik, ML et al, Investigational New Drugs, 1/1/2009
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
Hospital Affiliations
- NYU Langone HospitalsNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: